Becton Dickinson’s HUF 6 bln development to create 100 jobs in Hungary
Wikimedia Commons / Zephyris - black green yellow
United States-based medical technology company Becton Dickinson today laid the cornerstone of a HUF 6 mln production hall in Tatabánya, northwestern Hungary, next to its syringe plant, Hungarian news agency MTI reported.
Hypodermic needles: The black, green and yellow ones having been produced by Becton Dickinson. (Photo: Wikimedia Commons/Zephyris)
The development of the 10,500 sqm plant, which will produce reagents used in the pharmaceutical industry, is expected to create 100 jobs, out of which 60% are to be filled by those possessing a graduate degrees, James Borzi, the groupʼs vice president for global manufacturing, said, according to MTI.
The company currently employs 650 people in the country.
BD Medical-Pharmaceutical Systems opened a €100 mln syringe plant in the Tatabánya industrial park in 2010, and spent a further HUF 3 bln to expand the plant in 2014, MTI said.
According to the news agency, The company had revenue of HUF 11.8 bln in its 2013/14 business year, with exports accounting for close to HUF 10 bln.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.